Table 2.

Correlations between clinicopathologic features and prognosis of HCC patients

Characteristics	No. of patients	No. of events	Median survival time (95% CI)	Log-rank p
				OS	DFS
Total	363	229	34.0 (27.4-40.6)
Age (year)				0.157	0.281
≤50	187	123	30.0 (23.7-36.3)
<50	176	106	42.0 (32.5-51.5)
Gender				0.806	0.993
Female	63	40	38.0 (18.6-57.4)
Male	300	189	33.0 (25.9-40.1)
Family history				0.834	0.866
Absent	263	163	35.0 (29.6-40.4)
Present	81	54	39.0 (21.1-56.9)
Unknown	19	12
HBsAg				0.996	0.939
Negative	58	38	20.0 (0.000-41.4)
Positive	304	190	36.0 (29.5-42.5)
Unknown	1	1
AFP				0.009	0.007
Negative	142	79	51.0 (34.0-68.0)
Positive	215	144	28.0 (21.5-34.5)
Unknown	6	6
Tumor size (cm)				0.029	0.046
≤5	145	86	46.0 (35.6-56.4)
>5	153	92	24.0 (14.7-33.4)
Unknown	65	51
Differentiation				0.011	0.011
I+II	167	89	46.0 (33.36-58.64)
III+IV	128	89	30.0 (22.52-37.48)
Unknown	68	51
Tumor capsule				0.001	0.001
Absent	144	98	26.0 (14.4-37.6)
Present	146	77	47.0 (30.4-63.6)
Unknown	73	54
Cirrhosis				0.114	0.044
Absent	93	50	40.0 (13.3-66.7)
Present	199	126	33.0 (26.9-39.1)
Unknown	71	53
Venous invasion				0.041	0.078
Absent	199	119	39.0 (30.0-48.0)
Present	77	48	23.0 (16.0-30.0)
Unknown	87	62
HB history				0.684	0.604
Absent	148	92	35.0 (27.1-42.9)
Present	113	65	30.0 (20.3-39.7)
Unknown	102	72
Tumor number				0.491	0.442
Solitary	210	123	37.0 (26.3-42.7)
Multiple	65	41	31.0 (19.2-42.8)
Unknown	88	65
pTNM stage				0.001	<0.001
I	70	29	57.0 (33.2-80.8)
II	152	97	31.0 (23.3-39.9)
III	24	19	19.0 (0.000-44.3)
IV	12	11	6.0 (0.000-17.9)
Unknown	105	73

CI: Confidence interval; OS: Overall survival; DFS: Disease-free survival.